Correspondence |

Multisite Randomized Trial of Deep Brain Stimulation

Kenneth Follett, MD, PhD; Frances Weaver, PhD; Matthew Stern, MD; William Marks, MD; Penelope Hogarth, MD; Katherine Holloway, MD; Jeff Bronstein, MD; John Duda, MD; Stacy Horn, DO; Eugene Lai, MD; Ali Samii, MD
Arch Neurol. 2005;62(10):1643-1644. doi:10.1001/archneur.62.10.1643-b.
Text Size: A A A
Published online


The recent article by Anderson et al1 and the accompanying editorial by Okun and Foote2 regarding pallidal vs subthalamic nucleus deep brain stimulation (DBS) for Parkinson disease underscores the need for further research to establish the long-term benefits and potential risks of these treatment approaches. The Department of Veterans Affairs Cooperative Studies Program (Washington, DC), in collaboration with the National Institute of Neurological Disorders and Stroke (Bethesda, Md) and the DBS device manufacturer Medtronic (Minneapolis, Minn), has launched a multicenter, randomized trial of bilateral DBS of the globus pallidus vs subthalamic nucleus in persons with Parkinson disease. This landmark study involving 6 Department of Veterans Affairs Parkinson’s Disease Research, Education, and Clinical Centers and their university affiliates is well under way; 232 patients are enrolled toward the final cohort of 316. All sites have recognized expertise with medical and surgical treatment of Parkinson disease, including experience with globus pallidus and subthalamic nucleus DBS implantation and microelectrode recording. An additional component of the study compares DBS with the best medical therapy.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles
Long-term outcome of deep brain stimulation in generalised dystonia: a series of 60 cases. J Neurol Neurosurg Psychiatry Published online Apr 1, 2014.;
Posttraumatic Parkinsonism. J Head Trauma Rehabil Published online Apr 1, 2014.;